InMed Pharmaceuticals Inc. (OTCMKTS:IMLFF – Get Free Report) rose 7.2% during trading on Monday . The stock traded as high as $0.42 and last traded at $0.42. Approximately 326,020 shares changed hands during trading, an increase of 2,768% from the average daily volume of 11,369 shares. The stock had previously closed at $0.39. InMed Pharmaceuticals […]
Shares of InMed Pharmaceuticals Inc. (OTCMKTS:IMLFF – Get Free Report) traded up 4.4% on Monday . The company traded as high as $0.41 and last traded at $0.40. 35,832 shares changed hands during mid-day trading, an increase of 215% from the average session volume of 11,369 shares. The stock had previously closed at $0.38. InMed […]
InMed Pharmaceuticals (OTCMKTS:IMLFF – Get Free Report) and Prothena (NASDAQ:PRTA – Get Free Report) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, institutional ownership, valuation, profitability, earnings and dividends. Earnings & Valuation This table compares InMed Pharmaceuticals and […]
InMed Pharmaceuticals (OTCMKTS:IMLFF – Free Report) is one of 374 public companies in the “Biotechnology” industry, but how does it contrast to its competitors? We will compare InMed Pharmaceuticals to related companies based on the strength of its analyst recommendations, institutional ownership, risk, profitability, earnings, dividends and valuation. Profitability This table compares InMed Pharmaceuticals and […]
InMed Pharmaceuticals (OTCMKTS:IMLFF – Free Report) is one of 377 public companies in the “Biotechnology” industry, but how does it contrast to its peers? We will compare InMed Pharmaceuticals to similar companies based on the strength of its valuation, earnings, risk, dividends, institutional ownership, analyst recommendations and profitability. Earnings & Valuation This table compares InMed […]